These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 29844327)

  • 1. Interferon-gamma drives programmed death-ligand 1 expression on islet β cells to limit T cell function during autoimmune diabetes.
    Osum KC; Burrack AL; Martinov T; Sahli NL; Mitchell JS; Tucker CG; Pauken KE; Papas K; Appakalai B; Spanier JA; Fife BT
    Sci Rep; 2018 May; 8(1):8295. PubMed ID: 29844327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-1, but not PD-L1, expressed by islet-reactive CD4+ T cells suppresses infiltration of the pancreas during type 1 diabetes.
    Pauken KE; Jenkins MK; Azuma M; Fife BT
    Diabetes; 2013 Aug; 62(8):2859-69. PubMed ID: 23545706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective role of programmed death 1 ligand 1 (PD-L1)in nonobese diabetic mice: the paradox in transgenic models.
    Wang CJ; Chou FC; Chu CH; Wu JC; Lin SH; Chang DM; Sytwu HK
    Diabetes; 2008 Jul; 57(7):1861-9. PubMed ID: 18420489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue expression of PD-L1 mediates peripheral T cell tolerance.
    Keir ME; Liang SC; Guleria I; Latchman YE; Qipo A; Albacker LA; Koulmanda M; Freeman GJ; Sayegh MH; Sharpe AH
    J Exp Med; 2006 Apr; 203(4):883-95. PubMed ID: 16606670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous programmed death ligand-1 restrains the development and onset of Sjӧgren's syndrome in non-obese diabetic mice.
    Zhou J; Jin JO; Kawai T; Yu Q
    Sci Rep; 2016 Dec; 6():39105. PubMed ID: 27966604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut dysbiosis promotes islet-autoimmunity by increasing T-cell attraction in islets via CXCL10 chemokine.
    Pöysti S; Silojärvi S; Brodnicki TC; Catterall T; Liu X; Mackin L; Luster AD; Kay TWH; Christen U; Thomas HE; Hänninen A
    J Autoimmun; 2023 Nov; 140():103090. PubMed ID: 37572540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.
    Trembleau S; Penna G; Gregori S; Giarratana N; Adorini L
    J Immunol; 2003 Jun; 170(11):5491-501. PubMed ID: 12759426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC; Power RF
    J Immunol; 1995 May; 154(9):4874-82. PubMed ID: 7722337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.
    Paterson AM; Brown KE; Keir ME; Vanguri VK; Riella LV; Chandraker A; Sayegh MH; Blazar BR; Freeman GJ; Sharpe AH
    J Immunol; 2011 Aug; 187(3):1097-105. PubMed ID: 21697456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade.
    Kawada-Horitani E; Kita S; Okita T; Nakamura Y; Nishida H; Honma Y; Fukuda S; Tsugawa-Shimizu Y; Kozawa J; Sakaue T; Kawachi Y; Fujishima Y; Nishizawa H; Azuma M; Maeda N; Shimomura I
    Diabetologia; 2022 Jul; 65(7):1185-1197. PubMed ID: 35511238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B lymphocytes expressing high levels of PD-L1 are key regulators of diabetes development in non-obese diabetic mice.
    Chen K; Xue Q; Liu F; Liu L; Yu C; Bian G; Zhang K; Fang C; Song J; Ju G; Wang J
    Mol Immunol; 2019 Oct; 114():289-298. PubMed ID: 31419705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy.
    Tian C; Ansari MJ; Paez-Cortez J; Bagley J; Godwin J; Donnarumma M; Sayegh MH; Iacomini J
    J Immunol; 2007 Nov; 179(10):6762-9. PubMed ID: 17982066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.
    Chosich N; Harrison LC
    Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
    Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
    Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal relationship between immune cell influx and the expression of inducible nitric oxide synthase, interleukin-4 and interferon-gamma in pancreatic islets of NOD mice following adoptive transfer of diabetic spleen cells.
    Reddy S; Karanam M; Krissansen G; Nitschke K; Neve J; Poole CA; Ross JM
    Histochem J; 2000 Apr; 32(4):195-206. PubMed ID: 10872884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proinflammatory signaling in islet β cells propagates invasion of pathogenic immune cells in autoimmune diabetes.
    Piñeros AR; Kulkarni A; Gao H; Orr KS; Glenn L; Huang F; Liu Y; Gannon M; Syed F; Wu W; Anderson CM; Evans-Molina C; McDuffie M; Nadler JL; Morris MA; Mirmira RG; Tersey SA
    Cell Rep; 2022 Jun; 39(13):111011. PubMed ID: 35767947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse.
    Stephens LA; Kay TW
    Int Immunol; 1995 Dec; 7(12):1885-95. PubMed ID: 8746558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of autoimmune diabetes in NOD mice by troglitazone is associated with modulation of ICAM-1 expression on pancreatic islet cells and IFN-gamma expression in splenic T cells.
    Augstein P; Dunger A; Heinke P; Wachlin G; Berg S; Hehmke B; Salzsieder E
    Biochem Biophys Res Commun; 2003 May; 304(2):378-84. PubMed ID: 12711326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered PD-L1-Expressing Platelets Reverse New-Onset Type 1 Diabetes.
    Zhang X; Kang Y; Wang J; Yan J; Chen Q; Cheng H; Huang P; Gu Z
    Adv Mater; 2020 Jul; 32(26):e1907692. PubMed ID: 32449212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic Islet Cells Response to IFNγ Relies on Their Spatial Location within an Islet.
    De Burghgrave M; Lourenço C; Berthault C; Aiello V; Villalba A; Fouque A; Diedisheim M; You S; Oshima M; Scharfmann R
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.